A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
Clinical trial NCT05315167 · RECRUITING
Trial details
- NCT number
- NCT05315167
- Sponsor
- Zhuhai Yufan Biotechnologies Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2027-05-15
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.